| Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology N Rout-Pitt, N Farrow, D Parsons, M Donnelley Respiratory research 19, 1-10, 2018 | 214 | 2018 |
| Methods and devices useful for analyzing color medical images G McLennan, M Donnelley, D Gopalakrishnan, E Hoffman, J Reinhardt, ... US Patent 7,613,335, 2009 | 130 | 2009 |
| Public acceptability of gene therapy and gene editing for human use: a systematic review J Delhove, I Osenk, I Prichard, M Donnelley Human gene therapy 31 (1-2), 20-46, 2020 | 107 | 2020 |
| Challenges of up-scaling lentivirus production and processing A McCarron, M Donnelley, C McIntyre, D Parsons Journal of biotechnology 240, 23-30, 2016 | 107 | 2016 |
| Airway disease phenotypes in animal models of cystic fibrosis A McCarron, M Donnelley, D Parsons Respiratory research 19, 1-12, 2018 | 89 | 2018 |
| High‐resolution visualization of airspace structures in intact mice via synchrotron phase‐contrast X‐ray imaging (PCXI) DW Parsons, K Morgan, M Donnelley, A Fouras, J Crosbie, I Williams, ... Journal of Anatomy 213 (2), 217-227, 2008 | 74 | 2008 |
| Quantification of heterogeneity in lung disease with image-based pulmonary function testing CS Stahr, CR Samarage, M Donnelley, N Farrow, KS Morgan, G Zosky, ... Scientific reports 6 (1), 29438, 2016 | 64 | 2016 |
| Animal and cell culture models for cystic fibrosis: which model is right for your application? A McCarron, D Parsons, M Donnelley The American journal of pathology 191 (2), 228-242, 2021 | 63 | 2021 |
| Gene therapy for cystic fibrosis lung disease: overcoming the barriers to translation to the clinic M Donnelley, DW Parsons Frontiers in pharmacology 9, 417724, 2018 | 49 | 2018 |
| Long‐term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice P Cmielewski, M Donnelley, DW Parsons The journal of gene medicine 16 (9-10), 291-299, 2014 | 48 | 2014 |
| In vivo Dynamic Phase-Contrast X-ray Imaging using a Compact Light Source R Gradl, M Dierolf, B Günther, L Hehn, W Möller, D Kutschke, L Yang, ... Scientific Reports 8 (1), 6788, 2018 | 41 | 2018 |
| In Vitro, in Vivo, and Spectroscopic Assessment of Lead Exposure Reduction via Ingestion and Inhalation Pathways Using Phosphate and Iron Amendments F Kastury, E Smith, E Doelsch, E Lombi, M Donnelley, PL Cmielewski, ... Environmental science & technology 53 (17), 10329-10341, 2019 | 39 | 2019 |
| Large-scale production of lentiviral vectors using multilayer cell factories N Rout-Pitt, A McCarron, C McIntyre, D Parsons, M Donnelley Journal of Biological Methods 5 (2), 2018 | 37 | 2018 |
| Gene therapy for Cystic Fibrosis: Improved delivery techniques and conditioning with lysophosphatidylcholine enhance lentiviral gene transfer in mouse lung airways P Cmielewski, N Farrow, S Devereux, D Parsons, M Donnelley Experimental lung research 43 (9-10), 426-433, 2017 | 36 | 2017 |
| Phenotypic characterization and comparison of cystic fibrosis rat models generated using CRISPR/Cas9 gene editing A McCarron, P Cmielewski, N Reyne, C McIntyre, J Finnie, F Craig, ... The American journal of pathology 190 (5), 977-993, 2020 | 35 | 2020 |
| Dynamics of lead bioavailability and speciation in indoor dust and X-ray spectroscopic investigation of the link between ingestion and inhalation pathways F Kastury, E Smith, E Lombi, MW Donnelley, PL Cmielewski, DW Parsons, ... Environmental science & technology 53 (19), 11486-11495, 2019 | 34 | 2019 |
| A CAD system for long-bone segmentation and fracture detection M Donnelley, G Knowles, T Hearn Image and Signal Processing: 3rd International Conference, ICISP 2008 …, 2008 | 34 | 2008 |
| In Vivo X-Ray Imaging Reveals Improved Airway Surface Hydration after a Therapy Designed for Cystic Fibrosis KS Morgan, M Donnelley, N Farrow, A Fouras, N Yagi, Y Suzuki, ... American journal of respiratory and critical care medicine 190 (4), 469-472, 2014 | 32 | 2014 |
| Airway gene transfer in a non-human primate: lentiviral gene expression in marmoset lungs N Farrow, D Miller, P Cmielewski, M Donnelley, R Bright, DW Parsons Scientific reports 3 (1), 1287, 2013 | 32 | 2013 |
| Treatment of cystic fibrosis: From gene-to cell-based therapies KM Allan, N Farrow, M Donnelley, A Jaffe, SA Waters Frontiers in pharmacology 12, 639475, 2021 | 31 | 2021 |
David ParsonsRespiratory and Sleep Medicine, Women's and Children's Hospital; and Robinson Research InstituteVerified email at adelaide.edu.au
